Compliance & Persistence
This article deals with the question of how to handle costs to enhance medication adherence in trial-based pharmacoeconomic analyses. (Source: Pharmacoeconomics 2011)
The National Quality Forum recently endorsed the proportion of days covered (PDC)—a measure of medication adherence—as an indicator of quality in drug therapy management. (Source: J Manag Care Pharm. 2009;15(9):728-40 Copyright © 2009, Academy of Managed Care Pharmacy.)
The recognition that there is a lot wrong with the way health care is managed in the United States has been responsible for a good deal of controversy. Who, for example, should be in charge of medical decisions? What are the best practices? How can this be paid for? This little book steps back from the political arena to calmly address a different set of issues.(Source: JAMA, April 20, 2011, Leslie R. Martin, Kelly B. Haskard-Zolnierek, and M. Robin DiMatteo
The new law requires the Department of Health and Human Services (HHS) to develop national priorities for quality performance improvements and to develop new quality measures and metrics for providers of health care services.
This 35-page analysis, based on the responses of 146 organizations to the Healthcare Intelligence Network July 2011 survey on Improving Patient Satisfaction and the Patient Experience, presents the all-new data in more than 45 easy-to-follow graphs and tables. market research found that most respondents are dissatisfied with their patient satisfaction scores . An instant PDF download is available for $117.
MyDrugBenefit is a health plan’s single platform for empowering consumers to more appropriately use their prescription benefit – get the right therapy, at the right time, from the right source, based on both clinical and financial considerations.
Medication possession ratios (MPRs) tend to dominate the marketplace reporting tools for medication adherence programs, but the author argues that MPR is not, in fact, the best measure of medication adherence.
Cutting Edge Information is conducting a study to assess the different ways pharmaceutical companies are approaching patient adherence. This study aims to uncover the strategies and tactics that are working to keep patients on their treatment plans as well as examine the money invested in the most successful programs. Given the importance of this topic to all involved, there is much debate about how to find – and then fix – the root of the patient non-adherence problem. (Source: CuttingEdgeInfo)
Survey by The Benfield Group reports "Improving employees' medication compliance is among the top three priorities for a group of 75 employee benefit directors, medical directors, and other health management professionals with the ability to influence pharmacy benefits, according to a 2009 survey conducted by the Benfield Group for the National Pharmaceutical Council."More here. (Source:3/2011, Eve Bender, Mental Health Working)
Presentation at ISPOR Europe, Nov. 2011 by Andrew Lloyd DPhil, Vice President (Practice Lead), Oxford Outcomes, Oxford, UK
